Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Aruna Bio to Present at the 31st Annual Piper Jaffray Healthcare Conference


Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced that Dr. Mark Sirgo, Chief Executive Officer, and Dr. Steve Stice, Chief Scientific Officer, will be presenting at the 31st Annual Piper Jaffray Healthcare Conference in New York City on Thursday, December 5th at a new time of 9:30 AM Eastern Time.

The presentation will be webcast live and available on the events page of the Aruna Bio website (arunabio.com/events) and via the link below. A replay of the webcast will be available following the conference at arunabio.com/events.

Date: Thursday, December 5, 2019
Time: 9:30 AM Eastern Time
Webcast: https://event.webcasts.com/starthere.jsp?ei=1271874&tp_key=4093b6fa98

Drs. Sirgo and Stice will discuss the utilization of neural exosomes as both a therapeutic and a delivery vehicle to treat neurodegenerative diseases and stroke. The presentation will include data on Aruna Bio's proprietary neural exosome platform, which has demonstrated therapeutic benefit in multiple animal models of stroke and is also being developed for the treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Dr. Sirgo will also discuss the company's going forward strategy and key milestones for 2020.

About Aruna Bio
Aruna Bio is harnessing the natural abilities of neural exosomes to cross the blood brain barrier and enhance the body's anti-inflammatory, self-repair and protective mechanisms to treat a range of neurodegenerative disorders. Aruna Bio is also leveraging its proprietary exosomes and manufacturing platform to create synergistic therapies by enhancing exosomes with RNA, oligonucleotides, antibodies and small molecules. www.arunabio.com


These press releases may also interest you

at 02:00
Qi Card, the leading electronic payment solution and default national debit/credit card of Iraq, is paving the path toward financial inclusion with digital payments, salary-advance programs and personal loans that enable citizens to meet their...

at 02:00
There have been many false health news, hoaxes and biased information about the ongoing COVID-19 pandemic circulating on the net, and also in printed media and on TV. However, sometimes confusion and misinformation occur through official channels....

at 02:00
The proposed transaction is another step forward in DSM's evolution as a purpose-led, science-based company operating in the fields of Nutrition, Health, and Sustainable Living....

at 02:00
John S. Shegerian, Co-founder and Executive Chairman of ERI will serve as the Distinguished Speaker at the Virtual HIPAA Privacy and Security Summit. His presentation will address the timely problem that data is now stored on devices not...

at 01:17
At Dental South China International Expo, HeyGears announces two of its latest innovations in digital manufacturing solutions. First, HeyGears' clear aligner production solution that allows 24/7 mass production of clear aligner models and digitally...

at 01:00
RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company") and NeuroRx, Inc. have established supply chain agreements and ordered sufficient drug substance (RLF-100TM) to prepare to treat 1 million patients with COVID-19,...



News published on 21 november 2019 at 07:05 and distributed by: